Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

FDA grants accelerated approval to new treatment for children with Chagas disease

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease.

29 Aug 2017

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Panic disorder is a syndrome characterized by spontaneous and recurrent episodes of incapacitating anxiety. It typically emerges during adolescence or early adulthood and can take an exhausting emotional and physical toll on the body.

24 Aug 2017

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Mount Sinai experts offer tips on knowing risks and detecting symptoms of ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women and according to the National Cancer Institute, approximately 22,000 women will be diagnosed with the disease and 14,000 will die from it.

11 Aug 2017

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

The Centers for Disease Control and Prevention (CDC) has released a Health Alert Network (HAN) Health Advisory on 7th August 2017, Monday, in order to alert the health care facilities and the public health department on the increase in the reported cases of cyclosporiasis.

9 Aug 2017

Abdominal pain now due to dental braces swallowed 10 years earlier: Case report

In a rarely seen case, a 30-year-old woman presented to the doctors at the emergency department with a worsening pain at the centre of her abdomen. The pain was colicky over the last couple of days and on investigations the team of doctors found that it was due to something she had swallowed years earlier. The report of this case was published this week in the journal BMJ reports.

9 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

New online healthcare platform iDoc enables patients to book consultations with GPs anytime

Online digital healthcare provider iDoc, launches, with the aim of transforming the way patients access and interact with GPs and Paediatricians, nationally. Part of the Fidelity Health Group, iDoc offers patients the ability to have a GP appointment at a time and in a way, that suits them.

4 Aug 2017

Studies show how endoscopic procedures can improve outcomes and care

Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, features a study reporting that a simpler procedure for collecting biopsy specimens during various procedures can improve patient care, and a study showing how a relatively new procedure, POEM, has been adapted to help an additional set of patients with gastroparesis, a troubling stomach problem.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers reveal prevalence of unused prescription opioids following surgery

In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or none of the pills, and more than 90 percent failed to dispose of the leftovers in recommended ways.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Findings presented at the American Society for Microbiology's ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay in development for use on the Sgx Clarity™ system offers excellent sensitivity and may be a critical tool for improving the diagnosis of this life-threatening infection.

29 Jul 2017

Nausea News and Research

Further Reading

FDA grants accelerated approval to new treatment for children with Chagas disease

Acid-sensing receptor may have significant relevance to physiological response in panic disorder

Pork products associated with carrying hepatitis E virus in Britain

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Mount Sinai experts offer tips on knowing risks and detecting symptoms of ovarian cancer

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

Abdominal pain now due to dental braces swallowed 10 years earlier: Case report

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

New online healthcare platform iDoc enables patients to book consultations with GPs anytime

Studies show how endoscopic procedures can improve outcomes and care

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

HIV prevention drug to be trialed by Britain's NHS

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers reveal prevalence of unused prescription opioids following surgery

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News